Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-003009
Filing Date
2015-08-10
Accepted
2015-08-10 08:10:08
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q proteo_10q-063015.htm 10-Q 173095
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER proteo_ex3101.htm EX-31.1 8968
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER proteo_ex3102.htm EX-31.2 8949
4 CERTIFICATION proteo_ex3201.htm EX-32 5442
  Complete submission text file 0001019687-15-003009.txt   942564

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20150630.xml EX-101.INS 84523
6 XBRL SCHEMA FILE pteo-20150630.xsd EX-101.SCH 11982
7 XBRL CALCULATION FILE pteo-20150630_cal.xml EX-101.CAL 26119
8 XBRL DEFINITION FILE pteo-20150630_def.xml EX-101.DEF 13304
9 XBRL LABEL FILE pteo-20150630_lab.xml EX-101.LAB 87475
10 XBRL PRESENTATION FILE pteo-20150630_pre.xml EX-101.PRE 65834
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

EIN.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 151039239
SIC: 2834 Pharmaceutical Preparations